22. DIRECT MEDICAL COSTS FOR TYPE 2 DIABETES MELLITUS PATIENTS WITH COMPLICATIONS TREATED AT CHIEM HOA GENERAL HOSPITAL IN 2023

Tran Thuy Linh1, Nguyen Bach Ngoc1, Lam Thi Lan Anh1, Le Thi Thao Nguyen2, Nguyen Ngoc Hoai1, Dao Thi Linh1, Lam Thi Thanh Nga1, Dao Thu Thao1, Thai Van Trung1, Nguyen Van Hieu1, Do Thi Huyen3, Nguyen Duy Khanh1, Phan Huu Vinh1
1 School for Preventive Medicine and Public Health, Hanoi Medical University
2 Thanh Hoa Branch of Hanoi Medical University
3 Vinmec International General Hospital

Main Article Content

Abstract

Objective: To describe certain characteristics of Type 2 Diabetes Mellitus (T2DM) patients with complications and analyze the direct medical treatment costs for these patients at Chiêm Hóa General Hospital in 2023.


Methods: This is a cross-sectional descriptive study using electronic medical records of 1953 T2DM patients with complications receiving outpatient treatment at the Endocrinology Department of Chiêm Hóa General Hospital in 2023.


Results: Among the study subjects, 52.64% were male and 47.36% were female, predominantly aged 60-70 years and above 70 years. Neurological complications (36.04%) and cardiovascular complications (31.54%) were the most common. Among the cost components, the average annual medication cost was the highest at 4,592,936 VND per year. The total expenditure for renal complications was the highest (9,175,619 ± 4,256,098 VND).


Conclusion: The study provides a comprehensive overview of the disease status and medical costs for the treatment of T2DM with complications in Vietnam, highlighting the significant dependence on medication and testing costs. It underscores the importance of blood glucose control, regular disease management, and minimizing risk factors to prevent severe complications.

Article Details

References

[1] Dall T, Mann SE, Zhang Y, Martin J, Chen Y, Hogan P. Economic Costs of Diabetes in the U.S. in 2007. Diabetes Care. 2008;31 (3):596-615. doi:10.2337/dc08-9017
[2] Internationl Diabetes Federation. Global diabetes data report 2000 — 2045. https://diabetesatlas.org/data/.
[3] Seuring T, Archangelidi O, Suhrcke M. The Economic Costs of Type 2 Diabetes: A Global Systematic Review. Pharmacoeconomics. 2015;33 (8):811-831. doi:10.1007/s40273-015-0268-9
[4] Pham Huy Tuan Kiet, Kieu Thi Tuyet Mai, Duc Duong T, et al. Direct medical costs of diabetes and its complications in Vietnam: A national health insurance database study. Diabetes Res Clin Pract. 2020;162:108051. doi:10.1016/j.diabres.2020.108051
[5] Kautzky-Willer A, Leutner M, Harreiter J. Sex differences in type 2 diabetes. Diabetologia. 2023;66 (6):986-1002. doi:10.1007/s00125-023-05891-x
[6] Domeikienė A, Vaivadaitė J, Ivanauskienė R, Padaiga Ž. Direct cost of patients with type 2 diabetes mellitus healthcare and its complications in Lithuania. Medicina. 2014;50 (1):54-60. doi:10.1016/j.medici.2014.05.007
[7] Standards of Medical Care in Diabetes—2020 Abridged for Primary Care Providers | Clinical Diabetes | American Diabetes Association. https://diabetesjournals.org/clinical/article/38/1/10/32237/. Accessed June 9, 2024.
[8] William R, Van Gaal L, Lucioni C. Assessing the impact of complication on the costs of type II diabetes. 45:13-17. doi:10.1007/s00125-002-0859-9
[9] Cost of diabetes and its complications: results from a STEPS survey in Punjab, India | Global Health Research and Policy | Full Text. https://ghrp.biomedcentral.com/articles/10.1186/s41256-023-00293-3. Accessed June 9, 2024.
[10] Han G, Spencer MS, Ahn S, et al. Group-based trajectory analysis identifies varying diabetes-related cost trajectories among type 2 diabetes patients in Texas: An empirical study using commercial insurance. BMC Health Services Research. 2023;23 (1):1116. doi:10.1186/s12913-023-10118-1